Publications

Published

June 26, 2025

Note: This list is automatically parsed from my Google Scholar profile. I do my best to maintain the information, but there may still be inaccuracies present.

Code 
library(rvest)

parse_element <- function(node) {
  
  main <- html_element(node, ".gsc_a_t")
  year <- html_element(node, ".gsc_a_y") |> html_text()
  
  title <- main  |> html_element("a") |> html_text()
  tmpcite <- main |> html_elements(".gs_gray") |> html_text2()
  authors_short <- tmpcite[1]
  reference <- tmpcite[2]
  
  link <- paste0("https://scholar.google.com", main  |> html_element("a") |> html_attr("href"))
  
  data.frame(title = title, authors = authors_short, reference = reference, year = year, link = link)
    
}

google_scholar_url <- "https://scholar.google.com/citations?hl=en&user=txzZpf0AAAAJ&view_op=list_works&sortby=pubdate&pagesize=100&cstart=%s"

cstarts <- c(0, 100, 200) ## i will never have more than 300 pubs
pubdf <- NULL
for(i in cstarts) {
  
  doc <- read_html(sprintf(google_scholar_url, as.character(i)))
  publist <- doc |> html_elements(".gsc_a_tr")
  if((publist |> html_text())[1] == "There are no articles in this profile.") break
  
  pubdf <- c(pubdf, lapply(publist, parse_element))

}

pubdf <- do.call(rbind, pubdf)

  1. Evaluation of clinical utility in emulated clinical trials, J Hruza, A Sjölander, E Gabriel, S Bhatt, M Sachs. arXiv preprint arXiv:2506.03991, 2025. Google scholar link

  2. The next generation of regression standardization with the R package stdReg2, MC Sachs, JS Ohlendorff, A Brand, A Sjölander, EE Gabriel. Annals of Epidemiology 105, 66-74, 2025. Google scholar link

  3. Adding covariates to bounds: What is the question?, G Jonzon, EE Gabriel, A Sjölander, MC Sachs. arXiv preprint arXiv:2502.03156, 2025. Google scholar link

  4. Response to Dai et al, S Karlqvist, MC Sachs, C Eriksson, Y Cao, S Montgomery, JF Ludvigsson, …. Official journal of the American College of Gastroenterology| ACG 120 (1 …, 2025. Google scholar link

  5. The impact of coarsening an exposure on partial identifiability in instrumental variable settings, EE Gabriel, MC Sachs, A Sjölander. Biostatistics 26 (1), kxae042, 2025. Google scholar link

  6. Inflammatory plasma protein levels are elevated years before sarcoidosis diagnosis: a nested case–control study in Sweden, EV Arkema, MC Sachs, A Dominicus, A Eklund, A Smed-Sörensen, …. European Respiratory Journal 64 (6), 2024. Google scholar link

  7. Sharp symbolic nonparametric bounds for measures of benefit in observational and imperfect randomized studies with ordinal outcomes, EE Gabriel, MC Sachs, AK Jensen. Biometrika 111 (4), 1429-1436, 2024. Google scholar link

  8. Propensity weighting plus adjustment in proportional hazards model is not doubly robust, EE Gabriel, MC Sachs, I Waernbaum, E Goetghebeur, PF Blanche, …. Biometrics 80 (3), ujae069, 2024. Google scholar link

  9. Exact confidence intervals for functions of parameters in the k-sample multinomial problem, MC Sachs, EE Gabriel, MP Fay. arXiv preprint arXiv:2406.19141, 2024. Google scholar link

  10. Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case–control study in Sweden, M Dehara, S Kullberg, M Bixo, MC Sachs, J Grunewald, EV Arkema. European journal of epidemiology 39 (3), 313-322, 2024. Google scholar link

  11. Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation, EE Gabriel, MC Sachs, T Martinussen, I Waernbaum, E Goetghebeur, …. Statistics in Medicine 43 (3), 534-547, 2024. Google scholar link

  12. Flexible evaluation of surrogacy in platform studies, MC Sachs, EE Gabriel, A Crippa, MJ Daniels. Biostatistics 25 (1), 220-236, 2024. Google scholar link

  13. Increasing risk of lymphoma over time in Crohn’s disease but not in ulcerative colitis: a Scandinavian Cohort Study, O Olén, KE Smedby, R Erichsen, L Pedersen, J Halfvarson, …. Clinical Gastroenterology and Hepatology 21 (12), 3132-3142, 2023. Google scholar link

  14. Package ‘plotROC’, MC Sachs, RW Corty, L Crouch. Documentation, 2023. Google scholar link

  15. Sharp nonparametric bounds for decomposition effects with two binary mediators, EE Gabriel, MC Sachs, A Sjölander. Journal of the American Statistical Association 118 (544), 2446-2453, 2023. Google scholar link

  16. Cross-direct effects in settings with two mediators, EE Gabriel, A Sjölander, D Follmann, MC Sachs. Biostatistics 24 (4), 1017-1030, 2023. Google scholar link

  17. Suboptimal guideline adherence and biomarker underutilization in monitoring of post-operative Crohn’s disease, T Li, B Click, S Bachour, M Sachs, EL Barnes, BL Cohen, S Contreras, …. Digestive Diseases and Sciences 68 (9), 3596-3604, 2023. Google scholar link

  18. Early initiation of antitumor necrosis factor therapy reduces postoperative recurrence of Crohn’s disease following ileocecal resection, JE Axelrad, T Li, SP Bachour, TI Nakamura, R Shah, MC Sachs, S Chang, …. Inflammatory bowel diseases 29 (6), 888-897, 2023. Google scholar link

  19. Modifiable lifestyle risk factors for sarcoidosis: a nested case–control study, M Dehara, MC Sachs, J Grunewald, A Blomberg, EV Arkema. ERJ Open Research 9 (2), 2023. Google scholar link

  20. A general method for deriving tight symbolic bounds on causal effects, MC Sachs, G Jonzon, A Sjölander, EE Gabriel. Journal of Computational and Graphical Statistics 32 (2), 567-576, 2023. Google scholar link

  21. Confirmatory prediction-driven RCTs in comparative effectiveness settings for cancer treatment, A Brand, MC Sachs, A Sjölander, EE Gabriel. British Journal of Cancer 128 (7), 1278-1285, 2023. Google scholar link

  22. Nonparametric bounds for causal effects in imperfect randomized experiments, EE Gabriel, A Sjölander, MC Sachs. Journal of the American Statistical Association 118 (541), 684-692, 2023. Google scholar link

  23. Survival stacking with multiple data types using pseudo-observation-based-AUC loss, PG Ginestet, EE Gabriel, MC Sachs. Journal of Biopharmaceutical Statistics 32 (6), 858-870, 2022. Google scholar link

  24. Confidence bands in survival analysis, MC Sachs, A Brand, EE Gabriel. British Journal of Cancer 127 (9), 1636-1641, 2022. Google scholar link

  25. The association of serum vitamin D with incident diabetes in an African American population, JJ Joseph, S Langan, J Lunyera, B Kluwe, A Williams, H Chen, MC Sachs, …. Nutrition & Diabetes 12 (1), 43, 2022. Google scholar link

  26. Accessible computation of tight symbolic bounds on causal effects using an intuitive graphical interface, G Jonzon, MC Sachs, EE Gabriel. arXiv preprint arXiv:2209.03657, 2022. Google scholar link

  27. Age determines the risk of familial inflammatory bowel disease—a nationwide study, J Halfvarson, JF Ludvigsson, F Bresso, J Askling, MC Sachs, O Olén. Alimentary Pharmacology & Therapeutics 56 (3), 491-500, 2022. Google scholar link

  28. Comparative risk of serious infection with vedolizumab vs anti-TNF in inflammatory bowel disease: results from nationwide Swedish registers, S Karlqvist, MC Sachs, C Eriksson, Y Cao, S Montgomery, JF Ludvigsson, …. Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022. Google scholar link

  29. Event history regression with pseudo-observations: computational approaches and an implementation in R, MC Sachs, EE Gabriel. Journal of Statistical Software 102, 1-34, 2022. Google scholar link

  30. Causal bounds for outcome-dependent sampling in observational studies, EE Gabriel, MC Sachs, A Sjölander. Journal of the American Statistical Association 117 (538), 939-950, 2022. Google scholar link

  31. Direct modeling of relative and absolute risks in register data: mortality risk in sarcoidosis, EE Gabriel, EV Arkema, MC Sachs. Annals of Epidemiology 66, 1-4, 2022. Google scholar link

  32. Reproductive and hormonal risk factors for sarcoidosis: a nested case–control study, M Dehara, MC Sachs, S Kullberg, J Grunewald, A Blomberg, EV Arkema. BMC Pulmonary Medicine 22 (1), 43, 2022. Google scholar link

  33. Serious Infections in Pediatric Inflammatory Bowel Disease 2002-2017—A Nationwide Cohort Study, JF Ludvigsson, MC Sachs, J Järås, P Malmborg, O Olén. The Journal of pediatrics 238, 66-73. e1, 2021. Google scholar link

  34. Distinct metabolic profile associated with a fatal outcome in COVID-19 patients during the early epidemic in Italy, E Saccon, A Bandera, M Sciumè, F Mikaeloff, AA Lashari, S Aliberti, …. Microbiology Spectrum 9 (2), e00549-21, 2021. Google scholar link

  35. Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population: a nationwide register-based cohort study 2002–2017, JF Ludvigsson, J Holmgren, O Grip, J Halfvarson, J Askling, MC Sachs, …. Scandinavian journal of gastroenterology 56 (10), 1152-1162, 2021. Google scholar link

  36. On the Use of Nonparametric Bounds for Causal Effects in Null Randomized Trials, EE Gabriel, MC Sachs. American Journal of Epidemiology 190 (10), 2231-2231, 2021. Google scholar link

  37. Statin use and risk of inflammatory bowel diseases: authors’ reply, P Lochhead, H Khalili, MC Sachs, AT Chan, O Olén, JF Ludvigsson. Journal of Crohn’s and Colitis 15 (8), 1403-1404, 2021. Google scholar link

  38. Association between statin use and inflammatory bowel diseases: results from a Swedish, nationwide, population-based case-control study, P Lochhead, H Khalili, MC Sachs, AT Chan, O Olén, JF Ludvigsson. Journal of Crohn’s and Colitis 15 (5), 757-765, 2021. Google scholar link

  39. vedolizumab or a second anti‐TNF—no difference in efficacy for primary biologic failures with IBD. Authors’ reply., S Rundquist, MC Sachs, C Eriksson, O Olén, S Montgomery, J Halfvarson. Alimentary Pharmacology & Therapeutics 53 (9), 2021. Google scholar link

  40. Hepatobiliary cancer risk in patients with inflammatory bowel disease: a Scandinavian population-based cohort study, R Erichsen, O Olén, MC Sachs, L Pedersen, J Halfvarson, J Askling, …. Cancer Epidemiology, Biomarkers & Prevention 30 (5), 886-894, 2021. Google scholar link

  41. Reply: Survival in Crohn’s disease-associated small bowel adenocarcinoma, JE Axelrad, O Olén, MC Sachs, R Erichsen, L Pedersen, J Halfvarson, …. Gut 70 (5), 998-998, 2021. Google scholar link

  42. Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register–a validation study, G Bröms, J Söderling, MC Sachs, J Halfvarson, SWIBREG Study Group, …. Scandinavian Journal of Gastroenterology 56 (4), 410-421, 2021. Google scholar link

  43. No evidence of substantial underreporting of COVID-19 deaths in Taiwan during 2020, EYT Chen, MC Sachs, PW Dickman. Journal of the Formosan Medical Association 120 (9), 1788, 2021. Google scholar link

  44. anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors’ reply., S Rundquist, MC Sachs, C Eriksson, O Olén, S Montgomery, J Halfvarson. Alimentary Pharmacology & Therapeutics 53 (5), 2021. Google scholar link

  45. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden, JE Axelrad, O Olen, MC Sachs, R Erichsen, L Pedersen, J Halfvarson, …. Gut 70 (2), 297-308, 2021. Google scholar link

  46. Drug survival of anti‐TNF agents compared with vedolizumab as a second‐line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers, S Rundquist, MC Sachs, C Eriksson, O Olén, S Montgomery, J Halfvarson, …. Alimentary Pharmacology & Therapeutics 53 (4), 471-483, 2021. Google scholar link

  47. A unified evaluation of differential vaccine efficacy, EE Gabriel, MC Sachs, DA Follmann, TML Andersson. Biometrics 76 (4), 1053-1063, 2020. Google scholar link

  48. A novel method for quantifying intestinal inflammatory burden in inflammatory bowel disease using register data, JE Axelrad, MC Sachs, JF Ludvigsson, O Olén, SWIBREG Study Group. Clinical Epidemiology, 1059-1072, 2020. Google scholar link

  49. Decrease in primary but not in secondary abdominal surgery for Crohn’s disease: nationwide cohort study, 1990–2014, TD Kalman, ÅH Everhov, C Nordenvall, MC Sachs, J Halfvarson, …. Journal of British Surgery 107 (11), 1529-1538, 2020. Google scholar link

  50. Mortality of patients with microscopic colitis in Sweden, H Khalili, D Bergman, B Roelstraete, KE Burke, MC Sachs, O Olén, …. Clinical Gastroenterology and Hepatology 18 (11), 2491-2499. e3, 2020. Google scholar link

  51. Inflammatory bowel disease and pancreatic cancer: a Scandinavian register‐based cohort study 1969‐2017, ÅH Everhov, R Erichsen, MC Sachs, L Pedersen, J Halfvarson, J Askling, …. Alimentary Pharmacology & Therapeutics 52 (1), 143-154, 2020. Google scholar link

  52. Vagotomy and subsequent risk of inflammatory bowel disease: a nationwide register‐based matched cohort study, B Liu, A Wanders, K Wirdefeldt, A Sjölander, MC Sachs, M Eberhardson, …. Alimentary pharmacology & therapeutics 51 (11), 1022-1030, 2020. Google scholar link

  53. Colorectal cancer in Crohn’s disease: a Scandinavian population-based cohort study, O Olén, R Erichsen, MC Sachs, L Pedersen, J Halfvarson, J Askling, …. The lancet Gastroenterology & hepatology 5 (5), 475-484, 2020. Google scholar link

  54. Microscopic colitis and risk of inflammatory bowel disease in a nationwide cohort study, H Khalili, KE Burke, B Roelstraete, MC Sachs, O Olén, JF Ludvigsson. Gastroenterology 158 (6), 1574-1583. e2, 2020. Google scholar link

  55. Aim for clinical utility, not just predictive accuracy, MC Sachs, A Sjölander, EE Gabriel. Epidemiology 31 (3), 359-364, 2020. Google scholar link

  56. The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register, S Shrestha, O Olén, C Eriksson, ÅH Everhov, P Myrelid, I Visuri, …. Scandinavian Journal of Gastroenterology 55 (4), 430-435, 2020. Google scholar link

  57. Adult height in patients with childhood‐onset inflammatory bowel disease: a nationwide population‐based cohort study, N Mouratidou, P Malmborg, MC Sachs, J Askling, A Ekbom, M Neovius, …. Alimentary Pharmacology & Therapeutics 51 (8), 789-800, 2020. Google scholar link

  58. Work loss in relation to pharmacological and surgical treatment for Crohn’s disease: a population-based cohort study, ÅH Everhov, MC Sachs, JF Ludvigsson, H Khalili, J Askling, M Neovius, …. Clinical epidemiology, 273-285, 2020. Google scholar link

  59. Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964–2014, O Olén, J Askling, MC Sachs, M Neovius, KE Smedby, A Ekbom, …. Gut 69 (3), 453-461, 2020. Google scholar link

  60. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study, O Olén, R Erichsen, MC Sachs, L Pedersen, J Halfvarson, J Askling, …. The Lancet 395 (10218), 123-131, 2020. Google scholar link

  61. From high to low malaria transmission in Zanzibar—challenges and opportunities to achieve elimination, A Björkman, D Shakely, AS Ali, U Morris, H Mkali, AK Abbas, …. BMC medicine 17, 1-15, 2019. Google scholar link

  62. Ensemble prediction of time-to-event outcomes with competing risks: A case-study of surgical complications in Crohn’s disease, MC Sachs, A Discacciati, ÅH Everhov, O Olén, EE Gabriel. Journal of the Royal Statistical Society Series C: Applied Statistics 68 (5 …, 2019. Google scholar link

  63. Effects of childhood-onset inflammatory bowel disease on school performance: a nationwide population-based cohort study using Swedish Health and Educational Registers, P Malmborg, N Mouratidou, MC Sachs, U Hammar, H Khalili, M Neovius, …. Inflammatory bowel diseases 25 (10), 1663-1673, 2019. Google scholar link

  64. The biospecimen preanalytical variables program: a multiassay comparison of effects of delay to fixation and fixation duration on nucleic acid quality, LJ Carithers, R Agarwal, P Guan, H Odeh, MC Sachs, KB Engel, …. Archives of pathology & laboratory medicine 143 (9), 1106-1118, 2019. Google scholar link

  65. Gastrointestinal infection increases odds of inflammatory bowel disease in a nationwide case–control study, JE Axelrad, O Olén, J Askling, B Lebwohl, H Khalili, MC Sachs, …. Clinical Gastroenterology and Hepatology 17 (7), 1311-1322. e7, 2019. Google scholar link

  66. The Problem of Incomplete Validation in Reporting Prediction Models, MC Sachs. Official journal of the American College of Gastroenterology| ACG 114 (5 …, 2019. Google scholar link

  67. Optimizing and evaluating biomarker combinations as trial‐level general surrogates, EE Gabriel, MC Sachs, MJ Daniels, ME Halloran. Statistics in medicine 38 (7), 1135-1146, 2019. Google scholar link

  68. Fracture risk in patients with inflammatory bowel disease: a nationwide population-based cohort study from 1964 to 2014, JF Ludvigsson, M Mahl, MC Sachs, J Björk, K Michaelsson, A Ekbom, …. Official journal of the American College of Gastroenterology| ACG 114 (2 …, 2019. Google scholar link

  69. Increased mortality of patients with childhood-onset inflammatory bowel diseases, compared with the general population, O Olén, J Askling, MC Sachs, P Frumento, M Neovius, KE Smedby, …. Gastroenterology 156 (3), 614-622, 2019. Google scholar link

  70. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients, ÅH Everhov, MC Sachs, P Malmborg, C Nordenvall, P Myrelid, H Khalili, …. Scandinavian journal of gastroenterology 54 (1), 55-63, 2019. Google scholar link

  71. Inflammatory bowel disease and Parkinson’s disease: a nationwide Swedish cohort study, P Weimers, J Halfvarson, MC Sachs, R Saunders-Pullman, JF Ludvigsson, …. Inflammatory bowel diseases 25 (1), 111-123, 2019. Google scholar link

  72. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting—high coverage and safety, but no significant …, U Morris, MI Msellem, H Mkali, A Islam, B Aydin-Schmidt, I Jovel, SJ Shija, …. BMC medicine 16, 1-15, 2018. Google scholar link

  73. Small nucleolar RNA score: an assay to detect formalin-overfixed tissue, W Ammerlaan, J Trouet, MC Sachs, P Guan, L Carithers, P Lambert, …. Biopreservation and Biobanking 16 (6), 467-476, 2018. Google scholar link

  74. Association between inflammatory bowel disease and Parkinson’s disease: seek and you shall find?, P Weimers, J Halfvarson, MC Sachs, JF Ludvigsson, I Peter, O Olén, …. Gut, gutjnl-2018-316937, 2018. Google scholar link

  75. Evaluation and comparison of predictive individual-level general surrogates, EE Gabriel, MC Sachs, ME Halloran. Biostatistics 19 (3), 307-324, 2018. Google scholar link

  76. Measuring precision in bioassays: Rethinking assay validation, MP Fay, MC Sachs, K Miura. Statistics in medicine 37 (4), 519-529, 2018. Google scholar link

  77. Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden, ÅH Everhov, J Halfvarson, P Myrelid, MC Sachs, C Nordenvall, …. Gastroenterology 154 (3), 518-528. e15, 2018. Google scholar link

  78. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014, O Olén, J Askling, MC Sachs, P Frumento, M Neovius, KE Smedby, …. Bmj 358, 2017. Google scholar link

  79. plotROC: a tool for plotting ROC curves, MC Sachs. Journal of statistical software 79, 1-19, 2017. Google scholar link

  80. Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy, JL Lucas, EA Tacheny, A Ferris, M Galusha, AK Srivastava, A Ganguly, …. PLoS One 12 (8), e0182739, 2017. Google scholar link

  81. An introduction to principal surrogate evaluation with the pseval package, MC Sachs, EE Gabriel. The R journal 8 (2), 277, 2016. Google scholar link

  82. Issues in developing multivariable molecular signatures for guiding clinical care decisions, MC Sachs, LM McShane. Journal of Biopharmaceutical Statistics 26 (6), 1098-1110, 2016. Google scholar link

  83. Development and Validation of Predictive Signatures, MC Sachs, LM McShane. Cancer Clinical Trials, 133-166, 2016. Google scholar link

  84. Introduction to Principal Surrogate Evaluation in R, MC Sachs, EE Gabriel. Methods, 2016. Google scholar link

  85. Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer, EL Korn, MC Sachs, LM McShane. Annals of Oncology 27 (1), 10-15, 2016. Google scholar link

  86. Statistical principles for omics-based clinical trials, MC Sachs. Chinese Clinical Oncology 4 (3), 29-29, 2015. Google scholar link

  87. Robustness of next generation sequencing on older formalin-fixed paraffin-embedded tissue, DM Carrick, MG Mehaffey, MC Sachs, S Altekruse, C Camalier, …. PloS one 10 (7), e0127353, 2015. Google scholar link

  88. Comparing and combining biomarkers as principal surrogates for time‐to‐event clinical endpoints, EE Gabriel, MC Sachs, PB Gilbert. Statistics in medicine 34 (3), 381-395, 2015. Google scholar link

  89. Tools for estimating and predicting the cosinor model, M Sachs. Version, 2015. Google scholar link

  90. Translating Promising Biomarkers into Oncology Clinical Practice, TG Lively, MC Sachs, BA Conley. Oncology & Hematology Review 11 (1), 14-18, 2015. Google scholar link

  91. Estimated GFR and circulating 24, 25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials, IH De Boer, MC Sachs, M Chonchol, J Himmelfarb, AN Hoofnagle, JH Ix, …. American journal of kidney diseases 64 (2), 187-197, 2014. Google scholar link

  92. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS), JS Mathew, MC Sachs, R Katz, KK Patton, SR Heckbert, AN Hoofnagle, …. Circulation 130 (4), 298-307, 2014. Google scholar link

  93. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease, JM Ringman, MC Sachs, Y Zhou, SE Monsell, JL Saver, HV Vinters. JAMA neurology 71 (7), 878-883, 2014. Google scholar link

  94. Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis, B Kestenbaum, MC Sachs, AN Hoofnagle, DS Siscovick, JH Ix, …. Circulation: Heart Failure 7 (3), 409-417, 2014. Google scholar link

  95. Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis), AJ van Ballegooijen, B Kestenbaum, MC Sachs, IH de Boer, DS Siscovick, …. Journal of the American College of Cardiology 63 (12), 1214-1222, 2014. Google scholar link

  96. Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA), JP Linefsky, KD O’Brien, M Sachs, R Katz, J Eng, ED Michos, MJ Budoff, …. Atherosclerosis 233 (2), 331-337, 2014. Google scholar link

  97. Physical activity and change in estimated GFR among persons with CKD, C Robinson-Cohen, AJ Littman, GE Duncan, NS Weiss, MC Sachs, …. Journal of the American Society of Nephrology 25 (2), 399-406, 2014. Google scholar link

  98. 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis, M Blondon, M Sachs, AN Hoofnagle, JH Ix, ED Michos, C Korcarz, …. Arteriosclerosis, thrombosis, and vascular biology 33 (11), 2639-2645, 2013. Google scholar link

  99. No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease, R Mehrotra, CA Peralta, SC Chen, S Li, M Sachs, A Shah, K Norris, …. Kidney international 84 (5), 989-997, 2013. Google scholar link

  100. Parathyroid hormone and arterial dysfunction in the m ulti‐e thnic s tudy of a therosclerosis, C Bosworth, MC Sachs, D Duprez, AN Hoofnagle, JH Ix, DR Jacobs Jr, …. Clinical endocrinology 79 (3), 429-436, 2013. Google scholar link

  101. Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes, MC Sachs, JD Brunzell, PA Cleary, AN Hoofnagle, JM Lachin, ME Molitch, …. Diabetes care 36 (8), 2423-2429, 2013. Google scholar link

  102. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events, C Robinson-Cohen, AN Hoofnagle, JH Ix, MC Sachs, RP Tracy, …. Jama 310 (2), 2013. Google scholar link

  103. Partial summary measures of the predictiveness curve, MC Sachs, XH Zhou. Biometrical Journal 55 (4), 589-602, 2013. Google scholar link

  104. Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis, MC Sachs, A Shoben, GP Levin, C Robinson-Cohen, AN Hoofnagle, …. The American journal of clinical nutrition 97 (6), 1243-1251, 2013. Google scholar link

  105. Kidney disease and increased mortality risk in type 2 diabetes, M Afkarian, MC Sachs, B Kestenbaum, IB Hirsch, KR Tuttle, J Himmelfarb, …. Journal of the American Society of Nephrology 24 (2), 302-308, 2013. Google scholar link

  106. Paricalcitol does not improve glucose metabolism in patients with stage 3–4 chronic kidney disease, IH De Boer, M Sachs, AN Hoofnagle, KM Utzschneider, SE Kahn, …. Kidney international 83 (2), 323-330, 2013. Google scholar link

  107. Diabetes control and complication trial/epidemiology of diabetes interventions and complications study research group. circulating vitamin D metabolites and kidney disease in …, IH De Boer, MC Sachs, PA Cleary, AN Hoofnagle, JM Lachin, ME Molitch, …. J Clin Endocrinol Metab 97 (12), 4780-8, 2012. Google scholar link

  108. Circulating vitamin D metabolites and kidney disease in type 1 diabetes, IH De Boer, MC Sachs, PA Cleary, AN Hoofnagle, JM Lachin, ME Molitch, …. The Journal of Clinical Endocrinology & Metabolism 97 (12), 4780-4788, 2012. Google scholar link

  109. Clinical Predictors of Severe Cerebral Amyloid Angiopathy in Alzheimer’s Disease Patients, JM Ringman, M Sachs, M Beigi, PH Lu, JL Saver, HV Vinters. Neurology 76 (9), A662-A662, 2011. Google scholar link

  110. Statistical Methods to Assess the Prospective Predictive Accuracy of a Medical Test, M Sachs. University of Washington, 2011. Google scholar link

  111. P3‐040: Factors associated with brain autopsy in a large sample of decedents, M Sachs. Alzheimer’s & Dementia 6, S460-S461, 2010. Google scholar link

  112. Pharmacological treatment of Alzheimer’s disease: effect of race and demographic variables, S Hernandez, MKJ McClendon, XHA Zhou, M Sachs, AJ Lerner. Journal of Alzheimer’s disease 19 (2), 665-672, 2010. Google scholar link

  113. Total and cause-specific mortality in the cardiovascular health study, AB Newman, MC Sachs, AM Arnold, LP Fried, R Kronmal, M Cushman, …. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2009. Google scholar link

  114. Performance of maximum inspiratory pressure tests and maximum inspiratory pressure reference equations for 4 race/ethnic groups, MC Sachs, PL Enright, KD Hinckley Stukovsky, R Jiang, RG Barr. Respiratory care 54 (10), 1321-1328, 2009. Google scholar link

  115. Long‐term function in an older cohort—the Cardiovascular Health Study All Stars Study, AB Newman, AM Arnold, MC Sachs, DG Ives, M Cushman, ES Strotmeyer, …. Journal of the American Geriatrics Society 57 (3), 432-440, 2009. Google scholar link

  116. P4‐144: Factors associated with brain autopsy in a large multicenter sample of decedents: A multivariate analysis, M Sachs, T Koepsell. Alzheimer’s & Dementia 4, T712-T712, 2008. Google scholar link